share_log

Voting on CareCloud's Series A Proxy Continues With 82% of Early Proxies Favoring the Proposal

Voting on CareCloud's Series A Proxy Continues With 82% of Early Proxies Favoring the Proposal

關於CareCloud的A輪代理投票仍在繼續,早期的82%投票代理傾向於該提案。
GlobeNewswire ·  07/30 08:00

SOMERSET, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the "Series A Preferred Shareholders") of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of its' Series A Preferred Stock (the "Preferred Stock Proposal"). With approximately 20% of the shares of Series A Preferred Stock having already returned their proxies, 82% of these shares (up from 72% last week) are in favor of the changes recommended in the Preferred Stock Proposal.

2024年7月30日,新澤西州薩默塞特(SOMERSEt)—(環球資訊)-- CCLOUD公司。 (該公司)(納斯達克:CCLD,CCLDO,CCLDP),是一家爲全美醫療機構和健康系統提供醫療科技解決方案的領導者,現宣佈其11%的A系列永續優先股(A系列優先股)股東(系列A優先股股東)的代理請求持續進行,以批准修改公司的A系列優先股證明、優先權和權利(優先股提案)。已經有約20%的A系列優先股已經提交委託代理,其中82%(上週爲72%)贊成優先股提案所建議的更改。

"There are only three weeks remaining for Series A Preferred Shareholders to return their proxies on this important vote," said Stephen Snyder, President of CareCloud. "To become effective, the proposal must be approved by at least two-thirds of the shares of all outstanding Series A Preferred Stock – or about 3 million of the outstanding 4.5 million shares. Those wishing to submit their voting instructions can do so now through August 21, 2024, by calling 844-874-6164, by visiting , or by mailing back the completed proxy card received from CareCloud. Anyone who would rather attend the Special Meeting in person can do so by following the instructions contained in the Definitive Proxy materials."

CareCloud總裁史蒂芬·斯奈德稱:“A系列優先股股東只剩三週的時間提交委託投票,這是一項非常重要的投票。爲了生效,該提案必須獲得所有未流通A系列優先股的三分之二,即約300萬股的股份,的贊成批准。欲提交投票指示的人士現在可以通過撥打844-874-6164電話、訪問www.carecloudvote.com網站或將完成的委託代理卡郵寄回CareCloud的方式進行投票指示。任何願意親自參加特別會議的人,都可以按照《決定性委託材料》中所列出的指示進行操作。”

If the Preferred Stock Proposal is ultimately approved, holders of Series A Preferred Stock would receive similar change of control protections to those afforded to holders of the Company's Series B 8.75% Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock"). Also, the dividend of Series A Preferred Stock would mirror that of the Series B Preferred Stock, and the Company would, going forward, have the right to exchange the shares of Series A Preferred Stock for common stock at the liquidation preference value of the $25/share, plus accrued and unpaid dividends.

如果A優先股提案未獲批准,則其條款與發行A系列優先股時披露的說明相同。因此,公司的潛在收購者可以在收購公司的普通股的同時,將A系列優先股保留爲上市公司的證券。作爲收購後留存的證券的一個例子,投資者可能認爲新堡能源(NASDAQ:NFE)收購Golar LNG Partners(NASDAQ:GMLP)是一個有用的,儘管略有不同和可以區分的參考點。

Proxy solicitation is ongoing and the Company cannot predict future proxy or voting results, which could be more or less favorable than the trends seen to date. Any shares that are not voted will be deemed "no" votes, making it more difficult for the Company to achieve the minimum two-thirds vote in favor of the Preferred Stock Proposal.

本新聞稿中包含的信息是關於Definitive Proxy Statement及其它與SEC註冊有關的材料的部分摘要。對於A系列優先股東來說,重要的是仔細審查全部的備案材料,這些材料可在SEC網站和Important Additional Information and Where To Find It網站上獲取。CareCloud於2024年7月8日提交了一份《關於將來徵集代理的特別會議的14A表格的擔保委託書》,要求對A系列優先股股東(包括任何和所有的延期、推遲、繼續和重新安排)進行未來徵集代理。本新聞稿中包含的信息僅爲Proxy Statement的某些相關部分的摘要,對於A系列優先股股東來說,重要的是仔細審查所有文件的備案,這些文件是CareCloud免費通過SEC維護的網站獲得的。

The information contained in this press release is a summary of certain relevant portions of the Definitive Proxy Statement and other materials filed with the SEC. It is important that Series A Preferred Shareholders review the entirety of the filings, which are available on the SEC's website and on .

本新聞稿中所含信息是有關SEC提交的一份關於A股系列優先股股東特別會議的《擬施行的委託書》和其他文件的簡要概述。系列A優先股股東有必要仔細閱讀這些文件的所有內容,在SEC網站和www.carecloudvote.com網站上均可獲取。

About CareCloud

關於CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at .

CareCloud爲醫療保健業務帶來紀律性創新。我們的一套技術支持的解決方案可幫助客戶提高財務和運營績效,簡化臨床工作流程,提升患者體驗。超過40,000名提供者指望CareCloud幫助他們改善患者護理,同時降低行政負擔和運營成本。了解更多信息,包括營收循環管理(RCM)、實踐管理(PM)、電子健康記錄(EHR)、商業智能、患者體驗管理(PXM)和互聯網醫療。 .

Follow CareCloud on LinkedIn, Twitter and Facebook.

關注CareCloud的LinkedIn, 推特和頁面。Facebook.

Important Additional Information and Where To Find It. CareCloud filed with the SEC a definitive proxy statement on Schedule 14A on July 8, 2024, with respect to its future solicitation of proxies for the Special Meeting of Series A Preferred Stock shareholders (including any and all adjournments, postponements, continuations, and reschedulings thereof, the "Special Meeting"). The information contained in this press release is merely a summary of certain relevant portions of the Proxy Statement and it is important that Series A Preferred Stock shareholders review the entirety of the filing. SERIES A PREFERRED STOCK SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD'S FILING. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at www.sec.gov. The Notice of the Special Meeting of Series A Preferred Stockholders and our Proxy Statement for the Special Meeting, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 are available at www.sec.gov.

重要的額外信息和查詢途徑。CareCloud於2024年7月8日在SEC提交了關於未來的A股系列優先股股東特別會議徵集委託的《擬施行的委託書》(包括任何的和所有的休會、推遲、續期和重新安排)。本新聞簡介僅爲委託書的一部分內容。通過SEC網站可以免費獲得由CareCloud提交的這些文件以及其他文件。系列A優先股股東應認真仔細地閱讀《擬施行的委託書》和所有已提交或即將提交給SEC的修改和補充,因爲它們包含或將包含有關CareCloud提交的重要信息。

Forward-Looking Statements

前瞻性聲明

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could", "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other comparable terminology.

這些前瞻性陳述既不是歷史事實,也不是對未來業績的保證。相反,它們僅是預測,具有不確定性,涉及重大的已知和未知的風險,不確定性和其他因素,這些因素可能會導致我們或行業實際結果,活動水平或表現與這些前瞻性陳述所表達的任何未來結果,活動水平或表現實質上不同。即使迄今爲止這些陳述與其他內容不同,我們也無持續更新股東有關未來代理或投票趨勢的義務。新的風險和不確定性時常出現,我們無法預測所有可能對前瞻性陳述產生影響的風險和不確定性,包括但不限於:公司管理增長的能力,遷移新收效較小的客戶和保留新的和現有的客戶,保持具有成本效益的全球運營,提高操作效率並降低運營成本,預測並適當地調整與醫療保健行業的變化和其他行業法規和趨勢相關的變化,保留關鍵人員的服務,開發新技術,升級並使遺留的和收購的技術適應與不斷髮展的行業標準的工作,與在競爭對手產品和服務方面具有競爭力的其他公司爭奪,以及在公司的SEC備案中參考和討論的其他重要風險和不確定性。

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.

我們業務涉及的風險和不確定性很多,其中許多都超出了我們的控制能力,或是其中的一個或多個就能對我們的業績產生實質性影響,即便是前瞻性陳述最終被證明是正確的。在本新聞稿中,前瞻性陳述包括,但不僅限於,反映管理層對未來的財務表現和營運費用、預期增長、盈利能力和業務前景,疫情對我們的財務表現和業務活動的影響以及我們的收購的預期成果。這些前瞻性聲明既不是歷史事實,也不是未來業績的保證,而是預測未來,不確定的,涉及實質性已知和未知的風險、不確定性和其他因素,這些風險、不確定性和其他因素可能使我們(或我們所處的行業)的實際結果、活動數量或業績與這些前瞻性聲明所表達或暗示的未來結果、活動數量或業績有很大的不同。我們不必爲未來的委託或投票趨勢更新股東,即使它們與迄今爲止的情況有很大的不同。新的風險和不確定性時有出現,我們無法預測將會對前瞻性陳述產生影響的所有風險和不確定性,這些包括但不僅限於,公司管理增長、遷移新獲得的客戶和保留新老客戶、保持全球經營成本、提高運營效率並降低運營成本、預測和適應報銷和其他行業的規定和趨勢的變化、保留關鍵人員的服務、開發新的技術、升級和適應遺留和已獲得的技術符合不斷髮展的行業標準、與競爭對手公司的產品和服務進行競爭等重要的風險和不確定性,詳見公司向證券交易委員會提出的名爲“風險因素”的文件。

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We do not have an ongoing obligation to update shareholders regarding future proxy or vote trends, even if they are materially different from those experienced to date. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward- looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.

這些前瞻性聲明既不是歷史事實,也不是未來業績的保證。相反,它們只是預測,存在不確定性,並涉及大量已知和未知的風險、不確定性和其他因素,這些因素可能會導致我們(或我們所在的行業)的實際結果、活動水平或業績與這些前瞻性聲明所表達或暗示的任何未來結果、活動水平或業績存在實質性不同。即使未來的代理或投票趨勢與迄今爲止經驗到的趨勢具有實質性不同,我們也沒有繼續更新股東的義務。新的風險和不確定性會時常出現,對於所有可能會對前瞻性聲明產生影響的風險和不確定性(包括但不限於公司管理增長、遷移新收購客戶並保留新客戶和現有客戶、保持全球成本效益的運營、增加運營效率和降低運營成本、預測並適當調整報酬和其他行業法規和趨勢的變化、保留關鍵人員的服務、開發新技術、升級和適應傳統和獲得的技術來與不斷髮展的行業標準一起工作,與我們的競爭公司的產品和服務競爭以及其他重要風險和不確定性)無法進行預測。請參考並討論"風險因素"標題下在公司提交給證券交易委員會的文件中提到的所有重要風險和不確定性。

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

本新聞稿中的聲明是在本新聞稿的日期上其發佈,即使稍後在公司的網站上或以其他方式提供或公開,公司也不承擔更新向前看陳述的義務,以反映發生的事件或存在的情況。

SOURCE CareCloud

消息來源CareCloud

Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com

公司聯繫人:
Norman Roth
臨時首席財務官和公司財務控制器
CareCloud, Inc.
nroth@carecloud.com

Investor Contact:

投資者聯繫:

Bill Korn
CareCloud, Inc.
ir@carecloud.com

Bill Korn
CareCloud,Inc。
ir@carecloud.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論